COR
Cencora, Inc. · Healthcare · Medical - Distribution
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +2.0% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 163 | 0 | 140.71M | $39.83B | +5 | −4 |
| Q1 2026 | 165 | -4 | 143.75M | $45.15B | +4 | −9 |
| Q4 2025 | 168 | -1 | 154.98M | $52.35B | +1 | −1 |
| Q3 2025 | 24 | +1 | 95.47M | $29.83B | +1 | −1 |
| Q2 2025 | 21 | 0 | 79.61M | $23.87B | — | — |
| Q1 2025 | 18 | +1 | 37.02M | $10.29B | +2 | −1 |
| Q4 2024 | 17 | 0 | 34.14M | $7.67B | — | — |
| Q3 2024 | 16 | 0 | 25.36M | $5.70B | — | — |
| Q2 2024 | 16 | — | 24.85M | $5.60B | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 8.78M | -4.0% | $1.98B | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 8.78M | -4.0% | $1.98B | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 3 | Wellington Management ✦ | 5.19M | +7.0% | $1.17B | 0.2% | ▲ Add | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 5.19M | +7.0% | $1.17B | 0.2% | ▲ Add | 2 | SEC ↗ |
| 5 | Wellington Management ✦ | 5.19M | +7.0% | $1.17B | 0.2% | ▲ Add | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 5.19M | +7.0% | $1.17B | 0.2% | ▲ Add | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 5.19M | +7.0% | $1.17B | 0.2% | ▲ Add | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 5.19M | +7.0% | $1.17B | 0.2% | ▲ Add | 2 | SEC ↗ |
| 9 | Wellington Management ✦ | 5.19M | +7.0% | $1.17B | 0.2% | ▲ Add | 2 | SEC ↗ |
| 10 | Wellington Management ✦ | 5.19M | +7.0% | $1.17B | 0.2% | ▲ Add | 2 | SEC ↗ |
| 11 | Wellington Management ✦ | 5.19M | +7.0% | $1.17B | 0.2% | ▲ Add | 2 | SEC ↗ |
| 12 | Geode Capital Management ✦ (passive) | 4.20M | +4.7% | $941.18M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 13 | Geode Capital Management ✦ (passive) | 4.20M | +4.7% | $941.18M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 14 | Norges Bank ✦ (passive) | 1.73M | +8.1% | $388.51M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 1.46M | +34.7% | $328.04M | 0.5% | ▲ Add | 2 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 1.46M | +34.7% | $328.04M | 0.5% | ▲ Add | 2 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 1.46M | +34.7% | $328.04M | 0.5% | ▲ Add | 2 | SEC ↗ |
| 18 | Arrowstreet Capital ✦ | 970.19K | -8.3% | $218.37M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 19 | Two Sigma Investments ✦ | 860.62K | -3.9% | $193.71M | 0.5% | ▼ Trim | 2 | SEC ↗ |
| 20 | Marshall Wace ✦ | 495.85K | +7161.0% | $111.61M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 21 | Marshall Wace ✦ | 495.85K | +7161.0% | $111.61M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 22 | Millennium Management ✦ | 436.20K | -33.2% | $98.18M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 23 | D. E. Shaw & Co. ✦ | 282.67K | -23.9% | $63.62M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 24 | D. E. Shaw & Co. ✦ | 282.67K | -23.9% | $63.62M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 25 | Citadel Advisors ✦ | 238.12K | +1.2% | $53.60M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 26 | Bridgewater Associates ✦ | 237.45K | -7.0% | $53.45M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 27 | Renaissance Technologies ✦ | 228.90K | -35.6% | $51.52M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 28 | Adage Capital Partners ✦ | 195.66K | -33.1% | $44.04M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 29 | Gotham Asset Management ✦ | 50.93K | +92.1% | $11.46M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 30 | Fisher Asset Management ✦ | 927 | -14.6% | $208,820 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 3 holders, 139 shares, $43,570 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 11.30K sh · $3.66M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology